These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants. Isaacs A; Amarilla AA; Aguado J; Modhiran N; Albornoz EA; Baradar AA; McMillan CLD; Choo JJY; Idris A; Supramaniam A; McMillan NAJ; Muller DA; Young PR; Woodruff TM; Wolvetang EJ; Chappell KJ; Watterson D Front Immunol; 2022; 13():926262. PubMed ID: 35757714 [TBL] [Abstract][Full Text] [Related]
4. Fluorescent nanodiamond-based spin-enhanced lateral flow immunoassay for detection of SARS-CoV-2 nucleocapsid protein and spike protein from different variants. Wei-Wen Hsiao W; Sharma N; Le TN; Cheng YY; Lee CC; Vo DT; Hui YY; Chang HC; Chiang WH Anal Chim Acta; 2022 Oct; 1230():340389. PubMed ID: 36192062 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma. Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688 [TBL] [Abstract][Full Text] [Related]
6. Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies. Kim J; Kim D; Baek K; Kim M; Kang BM; Maharjan S; Park S; Choi JK; Kim S; Kim YK; Park MS; Lee Y; Kwon HJ Viruses; 2022 Dec; 15(1):. PubMed ID: 36680068 [TBL] [Abstract][Full Text] [Related]
7. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor. Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM Front Immunol; 2022; 13():871874. PubMed ID: 35898497 [TBL] [Abstract][Full Text] [Related]
8. Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum. Li J; Lillehoj PB ACS Sens; 2021 Mar; 6(3):1270-1278. PubMed ID: 33629833 [TBL] [Abstract][Full Text] [Related]
9. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection. Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK Front Immunol; 2021; 12():793953. PubMed ID: 34899762 [TBL] [Abstract][Full Text] [Related]
10. Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein. Zhou L; Mo C; Yang Y; Zhou Z; You A; Fan Y; Liu W; Li X; Zhou R; Tian X J Med Virol; 2023 Jan; 95(1):e28225. PubMed ID: 36238992 [TBL] [Abstract][Full Text] [Related]
11. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease. Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347 [TBL] [Abstract][Full Text] [Related]
12. Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron. Zhou B; Cheng L; Song S; Guo H; Shen S; Wang H; Ge X; Liu L; Ju B; Zhang Z Virol J; 2022 May; 19(1):96. PubMed ID: 35643510 [TBL] [Abstract][Full Text] [Related]
13. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies. Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184 [TBL] [Abstract][Full Text] [Related]
14. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail. Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986 [TBL] [Abstract][Full Text] [Related]
15. Smartphone-based sensitive detection of SARS-CoV-2 from saline gargle samples via flow profile analysis on a paper microfluidic chip. Akarapipad P; Kaarj K; Breshears LE; Sosnowski K; Baker J; Nguyen BT; Eades C; Uhrlaub JL; Quirk G; Nikolich-Žugich J; Worobey M; Yoon JY Biosens Bioelectron; 2022 Jul; 207():114192. PubMed ID: 35334331 [TBL] [Abstract][Full Text] [Related]
16. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection. Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model. Rak A; Gorbunov N; Kostevich V; Sokolov A; Prokopenko P; Rudenko L; Isakova-Sivak I Viruses; 2023 Jan; 15(1):. PubMed ID: 36680269 [TBL] [Abstract][Full Text] [Related]
18. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595 [TBL] [Abstract][Full Text] [Related]
19. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes. Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848 [TBL] [Abstract][Full Text] [Related]
20. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike. Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]